Search results
Results from the WOW.Com Content Network
OTC products will only work for mild cases of toenail fungus. As an example, Garg says that it may look like you only have one or two nails superficially affected — that is, the nail appears ...
In addition to other formulations, ciclopirox is used in lacquers for topical treatment of onychomycosis (fungal infections of the nails). A meta-analysis of the six trials of nail infections available in 2009 concluded that they provided evidence that topical ciclopirox had poor cure rates, and that amorolfine might be substantially more effective, but more research was required.
Recurrence may occur following treatment, with a 20-25% relapse rate within 2 years of successful treatment. [13] Nail fungus can be painful and cause permanent damage to nails. It may lead to other serious infections if the immune system is suppressed due to medication, diabetes or other conditions.
There are so many potential health problems that can afflict the feet ? like ingrown toenails, bunions, blisters, and even gout.
It is a topical solution for the treatment of toenail infections. [2] [3] Systemic treatments may be considered more effective. [1] It is approved for sale over-the-counter in Australia, Brazil, Russia, Germany, and the UK, and is approved for the treatment of toenail fungus by prescription in other countries. It is not approved for the ...
Before oral antifungal therapies are used to treat nail disease, a confirmation of the fungal infection should be made. [36] Approximately half of suspected cases of fungal infection in nails have a non-fungal cause. [36] The side effects of oral treatment are significant and people without an infection should not take these drugs. [36]
Johnson and Johnson's McNeil Consumer Healthcare recalled almost 800,000 bottles of Tylenol, Benadryl, Sudafed PE, and Sinutab products in two recalls linked to previous problems for the ...
Sinutab is a sinus, allergy and pain relief medication originally marketed by Warner–Lambert. It is manufactured and distributed by Johnson & Johnson after its acquisition of Pfizer 's consumer healthcare division in late December 2006.